메뉴 건너뛰기




Volumn 9, Issue 6, 2007, Pages 435-438

Aspirin withdrawal prior to invasive medical procedures: A strategy based on thromboembolic and bleeding risk stratification

Author keywords

Aspirin; Bleeding complication; Invasive procedure; Low molecular weight heparin; Thromboembolic risk

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN;

EID: 34250832132     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (24)
  • 1
    • 0024406369 scopus 로고    scopus 로고
    • Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989;321:129-35.
    • Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989;321:129-35.
  • 2
    • 0023845856 scopus 로고
    • Randomised trial of prophylactic daily aspirin in British male doctors
    • Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 1988;296:313-16.
    • (1988) Br Med J , vol.296 , pp. 313-316
    • Peto, R.1    Gray, R.2    Collins, R.3
  • 3
    • 0032562005 scopus 로고    scopus 로고
    • Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework
    • Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998;351:233-41.
    • (1998) Lancet , vol.351 , pp. 233-241
  • 4
    • 0032513878 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
    • Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62.
    • (1998) Lancet , vol.351 , pp. 1755-1762
    • Hansson, L.1    Zanchetti, A.2    Carruthers, S.G.3
  • 5
    • 0035852471 scopus 로고    scopus 로고
    • Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Collaborative Group of the Primary Prevention Project
    • de Gaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet 2001;357:89-95.
    • (2001) Lancet , vol.357 , pp. 89-95
    • de Gaetano, G.1
  • 6
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002;324:71-86.
    • (2002) Br Med J , vol.324 , pp. 71-86
  • 7
    • 0030220547 scopus 로고    scopus 로고
    • Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group
    • Goldstein RE, Andrews M, Hall WJ, Moss AJ. Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol 1996;28:326-30.
    • (1996) J Am Coll Cardiol , vol.28 , pp. 326-330
    • Goldstein, R.E.1    Andrews, M.2    Hall, W.J.3    Moss, A.J.4
  • 8
    • 0032411526 scopus 로고    scopus 로고
    • Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group
    • Harpaz D, Gottlieb S, Graff E, Boyko V, Kishon Y, Behar S. Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group. Am J Med 1998;105:494-9.
    • (1998) Am J Med , vol.105 , pp. 494-499
    • Harpaz, D.1    Gottlieb, S.2    Graff, E.3    Boyko, V.4    Kishon, Y.5    Behar, S.6
  • 9
    • 0037080429 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events: Recommendation and rationale
    • US Preventive Services Task Force
    • US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med 2002;136:157-60.
    • (2002) Ann Intern Med , vol.136 , pp. 157-160
  • 10
    • 0037118660 scopus 로고    scopus 로고
    • Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee
    • Pearson TA, Blair SN, Daniels SR, et al Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-91.
    • (2002) Circulation , vol.106 , pp. 388-391
    • Pearson, T.A.1    Blair, S.N.2    Daniels, S.R.3
  • 11
    • 1042268057 scopus 로고    scopus 로고
    • Aspirin therapy in diabetes
    • for the American Diabetes Association
    • Colwell JA, for the American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care 2004;27(Suppl 1):S72-3.
    • (2004) Diabetes Care , vol.27 , Issue.SUPPL. 1
    • Colwell, J.A.1
  • 13
    • 18044377421 scopus 로고    scopus 로고
    • Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis
    • Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med 2005;257:399-414.
    • (2005) J Intern Med , vol.257 , pp. 399-414
    • Burger, W.1    Chemnitius, J.M.2    Kneissl, G.D.3    Rucker, G.4
  • 14
    • 13244278145 scopus 로고    scopus 로고
    • Coronary syndromes following aspirin withdrawal: A special risk for late stent thrombosis
    • Ferrari E, Benhamou M, Cerboni P, Marcel B. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005;45:456-9.
    • (2005) J Am Coll Cardiol , vol.45 , pp. 456-459
    • Ferrari, E.1    Benhamou, M.2    Cerboni, P.3    Marcel, B.4
  • 15
    • 6444220783 scopus 로고    scopus 로고
    • Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes
    • Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004;110:2361-7.
    • (2004) Circulation , vol.110 , pp. 2361-2367
    • Collet, J.P.1    Montalescot, G.2    Blanchet, B.3
  • 16
    • 6944237687 scopus 로고    scopus 로고
    • Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
    • McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519-21.
    • (2004) Lancet , vol.364 , pp. 1519-1521
    • McFadden, E.P.1    Stabile, E.2    Regar, E.3
  • 17
    • 0033694607 scopus 로고    scopus 로고
    • Myocardial infarction after aspirin cessation in stable coronary artery disease patients
    • Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol 2002;76:257-8.
    • (2002) Int J Cardiol , vol.76 , pp. 257-258
    • Collet, J.P.1    Himbet, F.2    Steg, P.G.3
  • 18
    • 1842423453 scopus 로고    scopus 로고
    • Antiplatelet drug discontinuation is a risk factor for ischemic stroke
    • Sibon I, Orgogozo JM. Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 2004;62:1187-9.
    • (2004) Neurology , vol.62 , pp. 1187-1189
    • Sibon, I.1    Orgogozo, J.M.2
  • 20
    • 33750924102 scopus 로고    scopus 로고
    • A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease
    • Biondi-Zoccai GG, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006;27:2667-74.
    • (2006) Eur Heart J , vol.27 , pp. 2667-2674
    • Biondi-Zoccai, G.G.1    Lotrionte, M.2    Agostoni, P.3
  • 21
    • 0345742767 scopus 로고    scopus 로고
    • Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: Analysis of 1657 cases
    • Hui AJ, Wong RM, Ching JY, Hung LC, Chung SC, Sung JJ. Risk of colonoscopic polypectomy bleeding with anticoagulants and antiplatelet agents: analysis of 1657 cases. Gastrointest Endosc 2004;59:44-8.
    • (2004) Gastrointest Endosc , vol.59 , pp. 44-48
    • Hui, A.J.1    Wong, R.M.2    Ching, J.Y.3    Hung, L.C.4    Chung, S.C.5    Sung, J.J.6
  • 22
    • 0036617931 scopus 로고    scopus 로고
    • Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures
    • for the American Society for Gastrointestinal Endoscopy
    • Eisen GM, Baron TH, Dominitz JA, et al., for the American Society for Gastrointestinal Endoscopy. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002;55:775-9.
    • (2002) Gastrointest Endosc , vol.55 , pp. 775-779
    • Eisen, G.M.1    Baron, T.H.2    Dominitz, J.A.3
  • 23
    • 0036431992 scopus 로고    scopus 로고
    • Aspirin does not increase bleeding complications after transbronchial biopsy
    • Herth FJ, Becker HD, Ernst A. Aspirin does not increase bleeding complications after transbronchial biopsy. Chest 2002;122:1461-4.
    • (2002) Chest , vol.122 , pp. 1461-1464
    • Herth, F.J.1    Becker, H.D.2    Ernst, A.3
  • 24
    • 0032961496 scopus 로고    scopus 로고
    • The higher risk of bleeding in lung transplant recipients from bronchoscopy is independent of traditional bleeding risks: Results of a prospective cohort study
    • Diette GB, Wiener CM, White P Jr. The higher risk of bleeding in lung transplant recipients from bronchoscopy is independent of traditional bleeding risks: results of a prospective cohort study. Chest 1999;115:397-402.
    • (1999) Chest , vol.115 , pp. 397-402
    • Diette, G.B.1    Wiener, C.M.2    White Jr., P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.